Modulation of Signal Transducer and Activator of Transcription 3 (STAT3) Expression
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,479,993 | Modulation of Signal Transducer and Activator of Transcription 3 (STAT3) Expression In force · Low confidence | Ionis Pharmaceutials, Inc. | In force | Low confidence | ||
| US 8,816,056 | Modulation of Signal Transducer and Activator of Transcription 3 (STAT3)EXPRESSION In force · High confidence | Ionis Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,359,608 | Modulation of Signal Transducer and Activator of Transcription 3 (STAT3) Expression In force · High confidence | Isis Pharmaceuticals, Inc. | In force | High confidence |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Isis Pharmaceuticals, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.